NBC News | "His cancer treatment was failing. A fecal transplant turned it around."
NBC News interviewed the UCLA Fielding School of Public Health's Dr. Jonathan Jacobs, assistant professor-in-residence of epidemiology at FSPH and a gastroenterologist and microbiome researcher, about the results of fecal transplants in cancer treatment trials.
Jacobs, who also serves as co-director of the Goodman-Luskin Microbiome Center and an assistant professor with the David Geffen School of Medicine at UCLA, described the overall results as remarkable, given that all of these patients had advanced cancer and mere months to live.
“These early reports of patients who were previously immunotherapy-resistant but experienced clinical response after receiving FMT [fecal transplants] and immunotherapy retreatment are very exciting,” said Jacobs, who wasn’t involved with the trial.
In the news
